Pharmacokinetic determinants of carbapenem therapy in neonates and children

Pediatr Infect Dis J. 1996 Aug;15(8):733-7. doi: 10.1097/00006454-199608000-00034.
No abstract available

Publication types

  • Review

MeSH terms

  • Area Under Curve
  • Carbapenems / pharmacokinetics*
  • Carbapenems / pharmacology
  • Carbapenems / therapeutic use
  • Child
  • Child, Preschool
  • Gram-Negative Bacteria / drug effects
  • Gram-Positive Bacteria / drug effects
  • Humans
  • Imipenem / pharmacokinetics
  • Imipenem / pharmacology
  • Imipenem / therapeutic use
  • Infant
  • Infant, Newborn
  • Meropenem
  • Microbial Sensitivity Tests
  • Thienamycins / pharmacokinetics
  • Thienamycins / pharmacology
  • Thienamycins / therapeutic use

Substances

  • Carbapenems
  • Thienamycins
  • Imipenem
  • Meropenem